EMA — authorised 15 May 2002
- Marketing authorisation holder: H. Lundbeck A/S
- Status: approved
EMA authorised Namenda on 15 May 2002
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 15 May 2002.
H. Lundbeck A/S holds the EU marketing authorisation.